- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Mi | Modular Medical, Inc.: Modular Medical to Participate in the Association of Diabetes Care & Education Specialists 2026 Annual Conference | 224 | ACCESS Newswire | SAN DIEGO, CA / ACCESS Newswire / August 5, 2026 / Modular Medical, Inc ("Modular Medical" or "the Company") (NASDAQ:MODD), a commercial-stage medical device company preparing for the full commercial... ► Artikel lesen | |
| Di | Modular Medical to initiate first phase of Pivot pump launch in October | 1 | MassDevice | ||
| Mo | Modular Medical, Inc.: Modular Medical Announces Launch of Pivot Insulin Delivery System Across Five Key U.S. Markets Beginning October 2026 | 244 | ACCESS Newswire | First Phase of Strategic Rollout Targets Markets with Leading Insulin Pump Prescribers and Strong New Pump Adoption. Inizio will Provide Commercialization Expertise to Accelerate Awareness and Adoption... ► Artikel lesen | |
| 23.07. | Modular Medical forms advisory council for Pivot insulin pump | 3 | Investing.com | ||
| 23.07. | Modular Medical, Inc.: Modular Medical Announces Formation of Pivot Innovation Council and Appointment of Robert Gabbay, MD, PhD, FACP as Chairman | 277 | ACCESS Newswire | - Council to Provide Strategic Clinical Guidance on Commercialization, Patient Identification, Workflow Integration, and Evidence Generation SAN DIEGO, CA / ACCESS Newswire / July 23, 2026 / Modular... ► Artikel lesen | |
| MODULAR MEDICAL Aktie jetzt für 0€ handeln | |||||
| 17.07. | Modular Medical inks IMO Health collab for insulin pump EHR integration | 2 | MassDevice | ||
| 16.07. | Modular Medical partners with IMO Health on patient identification tool | 5 | Investing.com | ||
| 16.07. | Modular Medical und IMO Health entwickeln Algorithmus zur Identifizierung von Diabetespatienten | 2 | Investing.com Deutsch | ||
| 16.07. | Modular Medical, Inc.: Modular Medical and IMO Health Launch Strategic Pilot to Enable Real Time Insulin Pump Patient Identification Into Electronic Health Records | 316 | ACCESS Newswire | Pilot Combines Clinician Guided Phenotypes with IMO Health's Unique Terminology Identifiers to Help Clinicians Easily Identify Patients Most Likely to Benefit from Pivot Insulin Pump TherapyAdvancing... ► Artikel lesen | |
| 15.07. | Modular Medical, Inc.: Modular Medical Receives Research Demonstrating Positive Payor Reception of Pivot Tubeless Patch Pump | 220 | ACCESS Newswire | Completed Independent Study Strongly Supports Favorable Payor Receptivity to Pivot's Differentiated Design and Simplified User Experience, and provides further validation of significant progress towards... ► Artikel lesen | |
| 14.07. | Modular Medical, Inc.: Modular Medical Announces Completion of Research Initiative Indicating Strong Interest in Simpler Insulin Delivery | 345 | ACCESS Newswire | 97% of Surveyed Injection Users Would Consider Pump Therapy - if Easier to Learn and Improved OutcomesConducting Additional Research Initiative in Conjunction with Commercialization of the Pivot Tubeless... ► Artikel lesen | |
| 01.07. | Modular Medical reicht Software-Verbesserungen für Pivot-System bei FDA ein | 2 | Investing.com Deutsch | ||
| 01.07. | Modular Medical, Inc.: Modular Medical Announces FDA Submission of Pivot Tubeless Insulin Patch Pump Enhancements | 290 | ACCESS Newswire | Submission Covers Software Enhancements for Patient Flexibility and Customization of Pivot SAN DIEGO, CA / ACCESS Newswire / July 1, 2026 / Modular Medical, Inc. ("Modular Medical" or "the Company")... ► Artikel lesen | |
| 30.06. | Modular Medical startet kommerzielle Einführung seiner Insulinpumpe | 5 | Investing.com Deutsch | ||
| 30.06. | Modular Medical begins commercial insulin pump deployment | 2 | Investing.com | ||
| 30.06. | Modular Medical, Inc.: Modular Medical Delivers Insulin to First Patients on Pivot Tubeless Insulin Patch Pump | 396 | ACCESS Newswire | First Patients Began Device Training and Insulin Delivery Today, Marking Transition to a Commercial CompanyPivot is the First Insulin Pump Designed to Address the Large, Underserved Population of Insulin-Dependent... ► Artikel lesen | |
| 30.06. | EXCLUSIVE: Modular Medical Advances Commercial Rollout With First Active Users Of Pivot Insulin Pump | 2 | Benzinga.com | ||
| 29.06. | Modular Medical, Inc. - 10-K, Annual Report | 5 | SEC Filings | ||
| 26.06. | Modular Medical begins shipping Pivot insulin pump to doctors | 1 | Investing.com | ||
| 26.06. | Modular Medical, Inc.: Modular Medical Announces Shipment of Pivot Tubeless Patch Pumps | 295 | ACCESS Newswire | Pivot starter kits are now shipping to multiple endocrinology practices SAN DIEGO, CA / ACCESS Newswire / June 26, 2026 / Modular Medical, Inc. (NASDAQ:MODD) ("Modular Medical" or the "Company"), a... ► Artikel lesen |
1 2 3 4 Weiter >>
62 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| HEALWELL AI | 0,398 | -6,02 % | HEALWELL AI kündigt Telefonkonferenz zur Erörterung der Finanzergebnisse des zweiten Quartals 2026 für den 7. August 2026 an | HEALWELL AI wird am Freitag, den 7. August 2026, um 8:30 Uhr ET (5:30 Uhr PT) eine Telefonkonferenz und einen gleichzeitigen Webcast
abhalten
TORONTO, ON, 4. August 2026... ► Artikel lesen | |
| LIFEWARD | 7,280 | 0,00 % | Lifeward Ltd.: Lifeward Launches Pilot Program with Ottobock Care to Expand National Access to ReWalk Personal Exoskeleton | ||
| IMUNON | 1,330 | -2,92 % | Imunon, Inc.: IMUNON Reports Strong Enrollment Momentum in Phase 3 OVATION 3 Trial of IMNN-001 in Advanced Ovarian Cancer | Enrollment momentum exceeding expectations is based on highly promising survival (OS) data and well tolerated safety profile demonstrated in the Company's large, randomized Phase II study, OVATION... ► Artikel lesen | |
| INSPIRE MEDICAL SYSTEMS | 53,00 | +0,95 % | Inspire Medical Systems, Inc. Announces Second Quarter 2026 Financial Results, Raised 2026 Guidance, and Strategic Growth Plan | Generated second quarter revenue of $200.6 millionSecond quarter diluted EPS of $0.01; adjusted diluted EPS of $0.14Second quarter operating cash flow of $23.2 millionAnnounced strategic growth plan... ► Artikel lesen | |
| INSPIREMD | 0,635 | +1,60 % | InspireMD Inc.: InspireMD Appoints Carotid Intervention Commercial Leader Kathleen Kennedy as Senior Vice President of Global Sales and Marketing | MIAMI, July 30, 2026 (GLOBE NEWSWIRE) -- InspireMD, Inc. (Nasdaq: NSPR) ("InspireMD" or the "Company"), developer of the CGuard Prime carotid stent system for the prevention of stroke, today announced... ► Artikel lesen | |
| GT BIOPHARMA | 0,318 | +0,25 % | GT Biopharma, Inc.: GT Biopharma Announces First Patient Dosed in Phase 1 Trial of GTB-5550, a B7-H3-Targeted Natural Killer (NK) Cell Engager for Solid Tumors | GTB-5550 is now the 3rd TriKE- to enter the clinic and an expansion into a broader solid tumor opportunity, with the Phase 1 trial likely to focus on prostate cancer patients during the dose escalation... ► Artikel lesen | |
| MYOMO | 0,921 | -2,85 % | Myomo expects $45M-$47M full-year revenue while targeting second-half cash burn below $2M | ||
| INOGEN | 5,950 | +4,39 % | Inogen Inc - S-8, Securities to be offered to employees in employee benefit plans | ||
| INTELLIGENT BIO SOLUTIONS | 1,830 | +2,23 % | Intelligent Bio Solutions, Inc.: Intelligent Bio Solutions Completes Usability Study Supporting FDA 510(k) Submission | NEW YORK, Aug. 05, 2026 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) ("INBS" or the "Company"), a medical technology company delivering intelligent, rapid, non-invasive testing... ► Artikel lesen | |
| INCANNEX HEALTHCARE | 3,080 | 0,00 % | Incannex Healthcare: Incannex Commences Participant Screening in DReAMzz Phase 2 Study of IHL-42X for Obstructive Sleep Apnea | First clinical sites approved and actively screening potential participantsRepresents another major milestone in the advancement of IHL-42X towards Phase III developmentIHL-42X has received FDA Fast... ► Artikel lesen | |
| GLUCOTRACK | 0,521 | -0,76 % | Glucotrack, Inc. - 8-K, Current Report | ||
| LEXARIA BIOSCIENCE | 5,685 | +0,26 % | Lexaria Bioscience Corp.: Lexaria Announces Effective Date for Reverse Stock Split | KELOWNA, BC / ACCESS Newswire / July 30, 2026 / Lexaria Bioscience Corp. (Nasdaq:LEXX) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms, announces that it intends to effect... ► Artikel lesen | |
| LENSAR | 5,790 | -0,69 % | LENSAR, Inc.: LENSAR Reports First Quarter 2026 Results and Provides Business Update | 7 ALLY Robotic Cataract Laser Systems® ("ALLY System") Placements in First Quarter 2026; Backlog of 11 ALLY Systems as of March 31, 2026 First Quarter Recurring Revenue was $12.6 million Total Laser... ► Artikel lesen | |
| HEARTBEAM | 0,491 | -1,54 % | HeartBeam receives patent for multi-modal cardiac sensing device | ||
| MINIMED GROUP | 16,292 | +1,50 % | MiniMed appoints Alcon CEO David Endicott and Linnea Burman to its Board of Directors | David Endicott, Chief Executive Officer of Alcon, brings global healthcare leadership and public company experience; Linnea Burman adds MedTech operating depth NORTHRIDGE, Calif., June... ► Artikel lesen |
Das Unternehmen MODULAR MEDICAL INC kann der Branche Gesundheitswesen zugeordnet werden. Der aktuelle Kurs liegt bei 2,010 Euro und damit 0,00 % im Plus.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu MODULAR MEDICAL INC finden Sie auf Wallstreet Online.